Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Lorlatinib Tablets Lorbriqua 100MG

  • Product Name : Lorlatinib Tablets Lorbriqua 100MG
  • Category : Anti Cancer
  • Manufacturer Name : Pfizer
  • Trade Name : LORBRIQUA
  • Available Dosage : 100 MG
  • Packing : 10 Tablets
  • Pack Insert/Leaflet : 1 Pack (10 tablets)
  • Ingredients : Lorlatinib
  • Formulation : Tablet
  • Therapeutic use : Non-small cell lung cancer
  • Production Capacity : 100000

Description:-

Lorbriqua 100mg Tablet: Pioneering Progress in NSCLC Treatment


Empower your journey against non-small cell lung cancer (NSCLC) with the advanced formulation of Lorbriqua 100mg Tablet, featuring the potent lorlatinib. Meticulously designed for individuals with the distinctive ALK gene anomaly, this pharmaceutical breakthrough stands as a beacon of hope in the realm of oncology.


Navigating NSCLC Challenges: Understanding Lorbriqua's Realm


1. Unveiling the Core Component: Lorbriqua 100mg Tablet houses the dynamic lorlatinib, a transformative force in the treatment of NSCLC. As a beacon of progress, it addresses the uncontrolled proliferation of cells, hallmarking cancer's disruptive presence.


2. Tailored Treatment for ALK Gene Anomaly: Exclusively tailored for individuals with an abnormal ALK gene, Lorbriqua 100mg Tablet marks a paradigm shift in NSCLC therapy. The medication stands poised to curb the aberrant growth of cancer cells, reshaping the landscape of treatment possibilities.


Precautionary Dialogues: A Conversation with Your Healthcare Provider


Engage in open dialogue with your healthcare provider, shedding light on vital aspects of your medical history:


  • Cholesterol Levels: Discuss elevated cholesterol levels with your doctor.
  • Pancreatic Considerations: Unveil any history or existing concerns related to pancreatic issues.
  • Cardiac Health: Heart-related queries find a place in the conversation to ensure a comprehensive understanding.
  • Diabetic Dimensions: Diabetes-related considerations warrant discussion for nuanced treatment.
  • Renal Insights: Kidney health forms a crucial aspect to be disclosed during discussions.
  • Seizure History: Inform your doctor about any history of seizures for tailored guidance.
  • Mental Health: A history of depression should be shared for holistic care considerations.
  • Cardiopulmonary Factors: Chest pain and breathlessness experiences must find a place in the dialogue.
  • Pneumonitis History: Any past encounters with pneumonitis, especially lung conditions, should be communicated.
  • Health Safeguards during Treatment


Contraception Protocol: Adopt effective contraception measures throughout the treatment and for at least six months post the final dose.

Grapefruit Advisory: Avoid consuming grapefruit juice during the Lorbriqua 100mg Tablet regimen.

Sugar Sensitivity: If you have sugar intolerance, acknowledge it, given the lactose content in the medication.

Lorbriqua's Mission: Targeting NSCLC with Precision


1. Targeted Application: Lorbriqua 100mg Tablet meticulously targets tyrosine kinase enzymes, orchestrating a strategic assault on cancer cells.

2. ALK Gene Transformation: For patients with alterations in the ALK gene, Lorbriqua 100mg Tablet emerges as a shield against unbridled cancer cell growth.